PAYS vs. ZVRA
PAYS (PaySign, Inc.) and ZVRA (Zevra Therapeutics Inc.) are both stocks. PAYS operates in Software - Infrastructure (Technology), while ZVRA operates in Biotechnology (Healthcare). Over the past 10 years, PAYS returned 47.01%/yr vs -17.62%/yr for ZVRA. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
PAYS vs. ZVRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PAYS achieves a 73.98% return, which is significantly higher than ZVRA's 6.14% return. Over the past 10 years, PAYS has outperformed ZVRA with an annualized return of 47.01%, while ZVRA has yielded a comparatively lower -17.62% annualized return.
PAYS
- 1D
- -2.18%
- 1M
- 4.67%
- 6M
- 114.87%
- YTD
- 73.98%
- 1Y
- 20.43%
- 3Y*
- 68.29%
- 5Y*
- 27.49%
- 10Y*
- 47.01%
- ALL TIME*
- 14.52%
ZVRA
- 1D
- -1.35%
- 1M
- -31.14%
- 6M
- 5.67%
- YTD
- 6.14%
- 1Y
- -14.40%
- 3Y*
- 24.74%
- 5Y*
- -1.18%
- 10Y*
- -17.62%
- ALL TIME*
- -23.23%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
PAYS PaySign, Inc. | $4.75M | $4.21M | $5.00M |
| $18.33M | $18.68M | $21.76M |
PAYS vs. ZVRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PAYS PaySign, Inc. | 73.98% | 70.53% | 7.86% | 8.53% | 61.25% | -65.52% | -54.29% | 188.35% | 382.19% | 118.56% |
ZVRA Zevra Therapeutics Inc. | 6.14% | 7.43% | 27.33% | 42.70% | -47.30% | -22.23% | 84.70% | -78.71% | -56.05% | 37.29% |
Correlation
The correlation between PAYS and ZVRA is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.24 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.14 |
Correlation (All Time) Calculated using the full available price history since Apr 16, 2015 | 0.13 |
The correlation between PAYS and ZVRA shifts across timeframes, from 0.12 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
PAYS:
$500.92M
ZVRA:
$562.18M
PAYS:
$0.17
ZVRA:
$2.15
PAYS:
52.94
ZVRA:
4.43
PAYS:
6.02
ZVRA:
4.50
PAYS:
9.94
ZVRA:
2.78
PAYS:
$91.47M
ZVRA:
$122.29M
PAYS:
$46.93M
ZVRA:
$104.94M
PAYS:
$22.09M
ZVRA:
$149.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PAYS vs. ZVRA — Risk / Return Rank
PAYS
ZVRA
PAYS vs. ZVRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for PaySign, Inc. (PAYS) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PAYS | ZVRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.51 | ||
| Sortino ratioReturn per unit of downside risk | +0.82 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.02 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 0.37 | -0.36 | +0.73 |
| Martin ratioReturn relative to average drawdown | 0.74 | -0.65 | +1.39 |
Loading charts...
Drawdowns
PAYS vs. ZVRA - Drawdown Comparison
The maximum PAYS drawdown since its inception was -98.95%, roughly equal to the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for PAYS and ZVRA.
Loading charts...
Drawdown Indicators
| PAYS | ZVRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.95% | -99.27% | +0.32% |
Max Drawdown (1Y)Largest decline over 1 year | -55.59% | -40.40% | -15.19% |
Max Drawdown (3Y)Largest decline over 3 years | -64.60% | -43.47% | -21.13% |
Max Drawdown (5Y)Largest decline over 5 years | -64.60% | -60.97% | -3.63% |
Max Drawdown (10Y)Largest decline over 10 years | -93.09% | -97.85% | +4.76% |
Current DrawdownCurrent decline from peak | -50.08% | -97.48% | +47.40% |
Average DrawdownAverage peak-to-trough decline | -69.26% | -86.53% | +17.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.72% | 22.22% | +7.50% |
Volatility
PAYS vs. ZVRA - Volatility Comparison
The current volatility for PaySign, Inc. (PAYS) is 13.28%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 29.44%. This indicates that PAYS experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PAYS | ZVRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.28% | 29.44% | -16.16% |
Volatility (6M)Calculated over the trailing 6-month period | 52.10% | 49.17% | +2.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 70.23% | 65.35% | +4.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.40% | 61.11% | +6.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 75.75% | 81.05% | -5.30% |
Dividends
PAYS vs. ZVRA - Dividend Comparison
Neither PAYS nor ZVRA has paid dividends to shareholders.
Financials
PAYS vs. ZVRA - Financials Comparison
This section allows you to compare key financial metrics between PaySign, Inc. and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PAYS and ZVRA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZVRA has higher volatility (29.44%) compared to PAYS (13.28%). In terms of maximum drawdown, PAYS dropped -98.95% vs ZVRA's -99.27%.
PAYS currently has the higher Sharpe Ratio (0.29 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PAYS and ZVRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer